Home/Pipeline/Xpert® HAI Portfolio

Xpert® HAI Portfolio

C. difficile, MRSA/SA, Norovirus, Carba-R, vanA

ApprovedActive

Key Facts

Indication
C. difficile, MRSA/SA, Norovirus, Carba-R, vanA
Phase
Approved
Status
Active
Company

About Cepheid

Cepheid is a leader in molecular diagnostics, renowned for its fully integrated, automated GeneXpert system that delivers rapid, cartridge-based PCR test results. The company offers a broad menu of FDA-cleared and CE-marked tests across critical areas including respiratory infections, healthcare-associated infections (HAIs), tuberculosis, virology, and oncology. As a subsidiary of Danaher Corporation, Cepheid leverages its scale and operational excellence to drive global adoption, particularly through programs like 'Global Access' which aims to make essential tests like TB diagnostics available and affordable in low-resource settings.

View full company profile